Antimicrobial peptides: Defending the mucosal epithelial barrier
The recent epidemic caused by aerosolized SARS-CoV-2 virus illustrates the importance and vulnerability of the mucosal epithelial barrier against infection. Antimicrobial proteins and peptides (AMPs) are key to the epithelial barrier, providing immunity against microbes. In primitive life forms, AMP...
Main Authors: | Karen F. Johnstone, Mark C. Herzberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oral Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/froh.2022.958480/full |
Similar Items
-
Antimicrobial Peptide Expression at the Ocular Surface and Their Therapeutic Use in the Treatment of Microbial Keratitis
by: Allison H. Shannon, et al.
Published: (2022-06-01) -
Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2
by: Santosh K. Ghosh, et al.
Published: (2021-06-01) -
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01) -
Human Antimicrobial Peptides and Proteins
by: Guangshun Wang
Published: (2014-05-01) -
Comparison of salivary antimicrobial peptides and upper respiratory tract infections in elite marathon runners and sedentary subjects
by: Tatsuya Usui, et al.
Published: (2012-08-01)